Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

HCRN-GU22-587

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)

Status: Open to Accrual

Learn more:

Study Contact: studies@hoosiercancer.org; (317) 921-2050.

Abstracts/Posters/Presentations: 

  • M Serzan, O Jegede, R Alter, M Asim Bilen, D Braun, D Einstein, N Haas, H Hammers, D Herchenhorn, J King, K Runcie, J Sosman, C Sternberg, Y Yang, T Choueiri, S Signoretti, MB Atkins. Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587). Poster Presentation, 2024 ASCO. See abstract. 
  • M Serzan, O Jegede, R Alter, M Asim Bilen, D Braun, D Einstein, N Haas, H Hammers, D Herchenhorn, J King, K Runcie, J Sosman, C Sternberg, Y Yang, T Choueiri, S Signoretti, MB Atkins. Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587). Trials in Progress, 2024 ASCO GU. See abstract.